Catalyst Wire Dossier Catalyst Wire Dossier

BGC101 (EnEPC) Autologous Cell Therapy

· BioGenCell Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGC101 (EnEPC) Autologous Cell Therapy, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) [Phase 1, Phase 2]

See pricing